OTHER NEWS - April 27, 1993

Bergen Brunswig Plans European Venture: Bergen Brunswig Corp. made its first venture into the international market, proposing to pay $89 million for a 20% stake in Europe’s largest pharmaceuticals distributor. Bergen Brunswig and Cooperation Pharmaceutique Francaise, a Paris supplier of over-the-counter products, are bidding $443 million for all of Office Commercial Pharmaceutique’s stock. Bergen Brunswig, based in Orange, is the No. 2 U.S. drug wholesaler, with annual sales of about $6 billion. It would own 20% of the new joint venture, which would include OCP. Cooperation would be the majority shareholder. OCP has annual sales of about $6 billion.